Progress in research on molecular biology and application in dominant antigens ESAT6 and CFP10 of TB vaccine.
- Author:
Qin FAN
1
;
Lang BAO
Author Information
1. Institute of Infection and Immune, West China Medical Center, Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- MeSH:
Antigens, Bacterial;
chemistry;
genetics;
immunology;
Bacterial Proteins;
chemistry;
genetics;
immunology;
Humans;
Immunodominant Epitopes;
immunology;
Molecular Biology;
Peptide Fragments;
chemistry;
genetics;
immunology;
Tuberculosis Vaccines;
genetics;
immunology;
Vaccines, DNA;
immunology
- From:
Journal of Biomedical Engineering
2012;29(2):392-396
- CountryChina
- Language:Chinese
-
Abstract:
As the dominant antigens, early secreted antigenic target 6 (ESAT6, E6) and culture filtrate protein 10 (CFP10, C10) had once been the focus of tuberculosis (TB) vaccine due to their capability of inducing strong cell immune response in the host. They are also endowed with promising future of prevention against and diagnosis of TB. In this review, we systematically introduce recent research progress of E6 and C10, especially in structure-function, biological characteristics, protein expression and secretion, host immunity and vaccine development, and the prospects of their application are also discussed.
